Skip to content

Solid Biosciences Inc. SLDB Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-57.4%-2.1pp-109.9%-15.3pp-86.8%-21.0pp-68.2%-17.4pp-55.3%-9.5pp
Return on assets-50%-2.9pp-82.8%-12.2pp-68.8%-17.2pp-57.1%-15.5pp-47.1%-9.4pp
Return on invested capital-191.5%-65.3pp-161.1%+1.1pp-111%-20.5pp-118.3%-27.5pp-126.2%-5.3pp
Liquidity
Current ratio13.1×+2.2×6.1×+0.9×6.7×-1.1×9.3×-4.1×10.9×-4.0×
Quick ratio13.1×+2.2×6.1×+0.9×6.7×-1.1×9.3×-4.1×10.9×-4.0×
Cash ratio9.8×+2.5×1.8×-0.9×1.7×-1.1×4.7×-1.9×7.3×-0.9×
Leverage
Debt-to-equity0.1×0.0×0.1×-0.1×0.1×0.0×0.1×0.0×0.1×0.0×
Debt-to-assets0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Per Share
Book value per share$3.41-23.2%$2.06-38.8%$2.31-42.7%$2.74-41.9%$4.44-19.6%
Valuation
Market capitalization$910.66M+145%$439.41M+175%$480.45M+78.6%$376.34M+72.9%$286.72M-43.0%
Enterprise value$634.23M+244%$400.67M+286%$441.03M+92.3%$260.46M+77.1%$99.72M-75.7%
Price / book2.4×+1.2×2.4×+1.3×2.2×+0.6×1.5×+0.3×-1.4×
Free cash flow yield-19%+9.9pp-35.8%+27.2pp-27.7%+6.4pp-32.8%+6.9pp-37.4%-19.0pp
Earnings yield-21.1%+16.6pp-39.7%+38.4pp-34.8%+3.3pp-40.9%+0.7pp-48.7%-30.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Solid Biosciences Inc.'s ratios come from?
Every ratio is computed from Solid Biosciences Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.